|
|
||||||||
1 Section for Wildlife Diseases, National Veterinary Institute, PO Box 8156 Dep., N-0033 Oslo, Norway
2 Animal Disease Research Unit, USDA-ARS, and the Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, Washington 99164, USA
3 Section for Virology and Serology, National Veterinary Institute, PO Box 8156 Dep., N-0033 Oslo, Norway
4 Section for Immunoprophylaxis, National Veterinary Institute, PO Box 8156 Dep., N-0033 Oslo, Norway
5 Corresponding author (e-mail: turid.vikoren{at}vetinst.no)
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Malignant catarrhal fever has been reported in many species within Cervidae (Heuschele and Reid, 2001) including all of the four cervid species that are prevalent in natural populations in Nor-way: red deer (Cervus elaphus) (Reid et al., 1979), moose (Alces alces) (Andersson 1953; Altmann et al., 1973; Williams et al., 1984; Warsame and Steen 1989; Hänichen et al., 1998), roe deer (Capreolus capreolus) (Hänchen and Mannl 1984), and reindeer (Rangifer tarandus) (Altmann et al., 1973; Li et al., 1999). However, with the exception of Warsame and Steen (1989), reporting MCF in two free-ranging moose from Sweden, all reports comprise captive animals held in zoos, wildlife parks, or deer farms. In Norway, MCF is well known as a sporadic disease in domestic cattle, and the first case of MCF in cervids was diagnosed at the National Veterinary Institute (NVI) in a free-ranging moose in 1976. Since then, we have diagnosed another 15 cases in moose and in later years a few cases in free-ranging red deer and roe deer. The diagnoses were based upon pathologic findings that included the demonstration of the typical vasculitis and perivasculitis in the central nervous system (CNS) (Barker et al., 1993). We have also experienced two MCF outbreaks in semi-domesticated reindeer stalled in a sheep house for research purposes.
Our objectives were 1) to summarize pathologic lesions seen in free-ranging Norwegian cervids with the diagnosis MCF, 2) by means of polymerase chain reaction (PCR) to identify causative MCFV in tissues from these cases, and 3) to determine the prevalence of antibodies against MCFV in Norwegian cervids sampled during hunting.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
|
Polymerase chain reaction was run on paraffin-embedded, formalin-fixed tissues from 11 of the animals at the Animal Disease Research Unit, USDA-ARS (Table 2
). Thirty-one formalin-fixed, paraffin-embedded tissue blocks were examined by both OvHV-2specific PCR and CpHV-2specific PCR. The DNA from all tissue that was OvHV-2 PCR negative was subjected to amplification by PCR with degenerate primer targeting a portion of herpesviral DNA polymerase gene.
|
Additionally, frozen, nonfixed tissues from another four animals were examined by both OvHV-2specific PCR and a generic rhadinovirus PCR at the Section of Virology and Serology, NVI (Table 3
). DNA from the samples was isolated with DNeasy Tissue kit (Qiagen Nordic, Oslo, Norway) according to the manufacturers instructions. A single PCR, specific for OvHV-2, was performed using the outer primer set (556/755) of the protocol described by Baxter et al. (1993). The PCR was performed with the use of HotStar Taq DNA polymerase (Qiagen), with a final concentration of Mg2+ of 1.5 mM. Amplification consisted of an initial 15-min step at 95 C, followed by 42 cycles with the following conditions: 94 C for 50 s, 60 C for 15 s, and 72 C for 60 s. A final elongation step at 72 C was performed, followed by chilling to 4 C. Another PCR was performed on the samples, aimed at detecting a wider range of rhadinoviruses, using partly degenerated primers designed in the polymerase gene (RHV-1: 5'-TGT ACC CCA GCA TYA TCC AGG C, and RHV-2: 5': TTG ATR GCC AGC TGC TGC TT). The PCR was performed as above, but with an annealing temperature of 55 C instead of 60 C in the cycling conditions. Sequencing was performed on the purified PCR products, using the ABI PRISM BigDye Terminator Cycle Sequencing Ready Reaction kit v3.1 (Applied Biosystems Inc., Foster City, California, USA) according to the manufacturers instructions and analyzed on an ABI PRISM-Avant Genetic Analyser (Applied Biosystems). Software used for sequence analysis were Sequencher version 4.1.4 (Gene Codes Corporation, Ann Arbor, Michigan, USA, http://www.genecodes.com) and Fasta similarity search (Fasta, European Bioinformatics Institute, Cambridge, UK, http://www.ebi.ac.uk/).
|
The sera were tested for specific antibodies to MCFV by competitive inhibition enzyme-linked immunosorbent assay (cELISA) (Li et al., 2001b). The assay was developed using the monoclonal antibody (15-A) against an epitope conserved among all known members of the MCFV group of ruminant rhadinoviruses. These viruses include AlHV-1, AlHV-2, OvHV-2, CpHV-2, the virus of unknown origin causing MCF in white-tailed deer, and the MCF viruses carried by musk ox, ibex, and oryx (Li et al., 2003a). Sera were scored based on their ability to inhibit binding of 15-A monoclonal antibody to AlHV-1 antigens pre-coated onto microtiter plates. Sera that inhibited binding of the monoclonal antibody 25% greater than or equal to the negative control sera were considered positive (Li et al., 2001b).
| RESULTS |
|---|
|
|
|---|
At the laboratory, necropsy of one of the moose carcasses (M14) revealed alopecia and moderate crusting dermatitis primarily involving the legs, ears, and ventral thorax. Lymph nodes of the trunk were generally enlarged. Both eyes had fibrinopurulent conjunctivitis, peripheral corneal opacity, and small fibrin clots in the anterior chamber (Fig. 2
). There was bilateral purulent nasal discharge, and the mucosa of the nose, pharynx, and trachea were hyperemic and edematous with erosions and pseudomembranes. Large masses of fibrin and pseudomembranes were found in the bronchi of both lungs. In the oral cavity, multiple erosions were seen, particularly on the mucosal surface of the lips, and small longitudinal erosions were present in the anterior part of the esophagus (the gastrointestinal tract had been removed prior to submission). On the surface of the kidneys, small grayish foci were seen. The second moose carcass (M8) necropsied at the laboratory was extremely decomposed and no specific gross lesions were noted. In eight moose from which the head was submitted, eye lesions (hyperemic and swollen conjunctivas, corneal opacity and edema, and fibrin clots in the anterior chamber) were common findings, and less frequently purulent nasal discharge, erosions in the nasal mucosa, wet meninges with some cloudiness in the sulci, and edematous lymph nodes.
|
In 16 animals, vasculitis and perivasculitis characterized by infiltration of predominantly lymphoid cells, occurred in the parenchyma and leptomeninges of the brain and spinal cord (in two moose, M3 and 9, the CNS was not examined). The vasculitis most often affected the adventitia and media of medium-sized vessels (Fig. 3
). However, infiltration of the whole vessel wall and obliteration of the lumen was also seen (Fig. 4
). The intima often showed a marked hypertrophy of the endothelial cells (Fig. 4
). Perivascular edema and hemorrhages were common, and some vessels contained thrombi. Multifocal infiltrations of predominantly mononuclear cells occurred in the choroid plexus. Some of the animals also showed focal degenerative changes in nervous parenchyma, and gliosis.
|
|
|
Bacteriologic examination isolated Escherichia coli in one lung sample and one liver sample from two different moose, and in lungs and liver of a roe deer (R2). The remaining samples had growth of an unidentified mixture of bacteria.
Of 11 animals tested for the presence of MCFV DNA in formalin-fixed, paraffin-embedded tissues, three moose, one roe deer, and one red deer were positive for OvHV-2 DNA, and one moose was positive for CpHV-2 DNA (Table 2
). No signal was detected by the degenerate PCR in any of the tissues examined. Of the four animals in which PCR were run on frozen specimens, OvHV-2 DNA was detected in two moose (Table 3
). One moose and one roe deer were positive in the generic rhadinovirus PCR, and sequence analyses of the PCR products from these two animals showed that they shared more than 99.5% nucleotide sequence identity with known CpHV-2 sequence in the polymerase gene, indicating that they were infected with CpHV-2 (Table 3
). In summary, of 15 animals tested, OvHV-2 DNA was detected in five moose, one roe deer, and one red deer, whereas CpHV-2 DNA was found in two moose and one roe deer.
Antibodies against MCFV were found in 13 red deer (5%), nine reindeer (4%), five roe deer (2%), and one moose (0.4%). The red deer sera originated from six municipalities; five in western Norway, in which the seroprevalence ranged from 4 to 9%, and one in the southeastern part of the country, where no seropositive red deer was found among 27 examined. One (6%) of 16 captive red deer tested was seropositive.
| DISCUSSION |
|---|
|
|
|---|
The red deer, two roe deer, and 13 of the 15 examined moose had nonpurulent vasculitis and perivasculitis in the CNS typical of MCF (Barker et al., 1993). In the remaining two moose, the CNS was not examined, but both had histologic eye lesions consistent with MCF. Because few whole carcasses were examined, the overall picture of gross lesions could not be fully elucidated in this study. Lesions in the eye and the mucosa of the mouth and nose seem to be common findings in moose and red deer suffering from MCF. The variability in severity and distribution of the lesions found in individual moose presumably reflects an acute or subacute course of disease. No MCF specific gross lesions were found in the two roe deer carcasses examined, indicating a peracute/acute course of disease. Reid et al. (1986) found that roe deer inoculated with cells originating from MCFV-infected red deer developed typical MCF, but gave no description of the lesions. The only description of natural MCF infection in roe deer is given by Hänichen and Mannl (1984), reporting MCF in two fenced roe deer. One of these had gross lesions similar to those found in moose and red deer in the present study, whereas the other roe deer had signs of catarrhal abomasitis and enteritis. Thus, there also seems to be individual variation in roe deer during the course of the disease, and in the associated lesions.
The PCR results clearly indicated infections of OvHV-2 and CpHV-2 origin in the cervids in the present study, suggesting both sheep and goat as sources of infection. The sheep-associated MCF cases in free-ranging cervids were scattered throughout Norway (Fig. 1
). Sheep farming is common in most parts of the country (Statistics Norway, 2005) and sheep and cervids often share pastures in the woods and mountains during summer. Goat farming is not so common and far less widespread: it is mainly located in the western and northern part of the country (Statistics Norway, 2005). The three CpHV-2 positive cervids all came from municipalities in the eastern part of Nor-way (Fig. 1
), where there are no registered goat farms. However, the moose is not a stationary species, and reported moose might have been infected in areas distant from the locations in which they were found. Another explanation might be that species other than the goat, for example, the cervid species themselves, might carry CpHV-2 and be the source of infection. Li et al. (2003b) found CpHV-2 DNA in peripheral blood leukocytes from two healthy farmed white-tailed deer, which indicates a subclinical or latent infection in these individuals. Persistent MCFV infection has also been demonstrated in cattle and farmed deer with no evidence of MCF disease, as well as in recovered cattle (OToole et al., 1997; Tham, 1997).
The PCR examination of formalin-fixed, paraffin-embedded tissues failed to demonstrate OvHV-2 and CpHV-2 DNA in five out of 11 animals tested. The reason for the failure is not clear. Possible explanations include: 1) low level of viral DNA in tissues of affected animal; or 2) prolonged fixation of the tissues in formalin. It is still not known whether the levels of OvHV-2 DNA in tissues of affected cervids are the same as the levels in cattle or bison; virtually all formalin-fixed, paraffin-embedded tissue samples from these species yielded positive signals by PCR, despite the fact that formalin fixation of tissues can significantly reduce test sensitivity (Crawford et al., 1999). The PCR failure to amplify OvHV-2 DNA in formalin-fixed tissues from cervids with suspect clinical MCF has been previously reported (Hänichen et al., 1998; Li et al., 1999). Considering that the histologic lesions in these five moose were in concordance with those from individuals found positive for OvHV-2 or CpHV-2 DNA, it seems unlikely that these five are true negatives, unless the animals were infected with another so-far-unrecognized MCF-virus.
A low prevalence (0.45%) of seropositive animals to MCFV was found in the four species examined, with the highest seroprevalence occurring in red deer. This result is similar to other serosurveys in these species (Li et al., 1996; Frölich et al. 1998; Zarnke et al., 2002). Two of these studies (Li et al., 1996; Frölich et al., 1998) used the originally developed cELISA method (Li et al., 1994) and Zarnke et al. (2002) used the same improved cE-LISA method as this study (Li et al., 2001b). The seroprevalences found in wild reindeer and moose in Norway were almost identical to those found in these two species in Alaska (4 and 1%, respectively) (Zarnke et al., 2002). In a survey from Germany, no seropositive animals were found among 253 wild roe deer and 22 wild red deer tested (Frölich et al., 1998). A more heterogeneous picture in prevalence has been found in North American elk. A prevalence of 9% was found in a total of 323 free-ranging elk from five different states in the US, and the authors reported that there was no apparent difference in seroprevalence between the states of origin (Li et al., 1996). Zarnke et al. (2002) found discrepancy in prevalence between two elk populations in Alaska; one showed 35% seropositivity amongst 40 tested whilst the other population had no positive animals among the 11 examined. We tested red deer from six municipalities in which the seroprevalence ranged from 0 to 9%. Sheep farms are very common in western Norway where all the seropositive red deer were found, enabling good opportunities for virus transmission to red deer.
Our serologic findings support the conclusions of Li et al. (1996) that a significant number of nonlethal MCFV infections occur among clinically susceptible cervids. However, the low seroprevalence found in moose and roe deer indicate a more likely lethal outcome of a MCFV infection in these two species, as compared to red deer and reindeer. Whether the seropositive cervids reflect a subclinical infection, or represent individuals that have recovered from clinical MCF, is an open question. We found one seropositive captive red deer, which, according to the history of the owner, is not likely to have suffered clinical MCF. This supports the suggestion that a MCFV infection can be subclinical in red deer. An interesting question that needs further research is whether cervids themselves may constitute a primary source of MCFV infection.
| ACKNOWLEDGMENTS |
|---|
| LITERATURE CITED |
|---|
|
|
|---|
ANDERSSON, P. 1953. Ett fall av elakartad katarralfeber hos älg. (A case of malignant catarrhal fever in moose.) Nordisk Veterinærmedicin 5: 847854 (In Swedish).
BARKER, I. K., A. A. VAN DREUMEL, AND N. PALMER. 1993. Malignant catarrhal fever. In Pathology of domestic animals, Vol. 2, 4th Edition, K. V. F. Jubb, P. C. Kennedy and N. Palmer (eds.). Academic Press Inc., San Diego, California, pp. 163173.
BAXTER, S. I., I. POW, A. BRIDGEN, AND H. W. REID. 1993. PCR detection of the sheep-associated agent of malignant catarrhal fever. Archives of Virology 132: 145159.[Medline]
CRAWFORD, T. B., H. LI, AND D. OTOOLE. 1999. Diagnosis of malignant catarrhal fever by PCR using formalin-fixed, paraffin-embedded tissues. Journal of Veterinary Diagnostic Investigation 11: 111116.
, , S. R. ROSENBURG, R. W. NORHAUSEN, AND M. M. GARNER. 2002. Mural folliculitis and alopecia caused by infection with goat-associated malignant catarrhal fever virus in two sika deer. Journal of the American Veterinary Medical Association 221: 843847.[Medline]
CULLING, C. F. A., R. T. ALLISON, AND W. T. BARR. 1985. Cellular pathology technique, 4th Edition. Butterworth & Co. Ltd., London, UK, 642 pp.
FROLICH, K., H. LI, AND U. MULLER-DOBLIES. 1998. Serosurvey for antibodies to malignant catarrhal fever-associated viruses in free-living and captive cervids in Germany. Journal of Wildlife Diseases 34: 777782.[Abstract]
HANICHEN, T., AND A. MANNL. 1984. Bösartiges Katarrhalfieber bei im Gatter gehalten Rehen (Capreolus capreolus). Verhandlungsbericht des Internationalen Symposium über die Erkrankungen der Zootiere 26: 355361.
, H. W. REID, H. WIESNER, AND W. HERMANNS. 1998. Bösartiges Katarrhalfieber bei Zoowiederkäuern. Tierärtzlicher Praxis 26: 294300.
HEUSCHELE, W. P., AND H. W. REID. 2001. Malignant catarrhal fever. In Infectious diseases of wild mammals, 3rd Edition, E. S. Williams and I. K. Baker (eds.). State University Press, Ames, Iowa, pp. 157164.
KEEL, M. K., J. G. PATTERSON, T. H. NOON, G. A. BRADLEY, AND J. K. COLLINS. 2003. Caprine herpesvirus-2 in association with naturally occurring malignant catarrhal fever in captive sika deer (Cervus nippon). Journal of Veterinary Diagnostic Investigation 15: 179183.
KLEIBOEKER, S. B., M. A. MILLER, S. K. SCHOMMER, J. A. RAMOS-VARA, M. BOUCHER, AND S. E. TURNQUIST. 2002. Detection and multigenic characterization of a herpesvirus associated with malignant catarrhal fever in white-tailed deer (Odocoileus virginianus) from Missouri. Journal of Clinical Microbiology 40: 13111318.
LI, H., D. T. SHEN, D. P. KNOWLES, J. R. GORHAM, AND T. B. CRAWFORD. 1994. Competitive-inhibition enzyme-linked immunosorbent assay for antibody in sheep and other ruminants to a conserved epitope of malignant catarrhal fever virus. Journal of Clinical Microbiology 32: 16741679.
, K. GAILBREATH, D. OTOOLE, D. P. KNOWLES, J. R. GORHAM, AND T. B. CRAWFORD. 1995. Investigation of sheep-associated malignant catarrhal fever virus infection in ruminants by PCR and competitive inhibition enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 33: 20482053.[Abstract]
, , D. A. JESSUP, D. P. KNOWLES, J. R. GORHAM, T. THORNE, D. OTOOLE, AND T. B. CRAWFORD. 1996. Prevalence of antibody to malignant catarrhal fever virus in wild and domestic ruminants by competitive-inhibition ELISA. Journal of Wildlife Diseases 32: 437443.[Abstract]
, W. C. WESTOVER, AND T. B. CRAWFORD. 1999. Sheep-associated malignant catarrhal fever in a petting zoo. Journal of Zoo and Wildlife Medicine 30: 408412.[Medline]
, N. DYER, J. KELLER, AND T. B. CRAWFORD. 2000. Newly recognized herpesvirus causing malignant catarrhal fever in white-tailed deer (Odocoileus virginianus). Journal of Clinical Microbiology 38: 13131318.
, J. KELLER, D. P. KNOWLES, AND T. B. CRAWFORD. 2001a. Recognition of another member of the malignant catarrhal fever virus group: An endemic gammaherpesvirus in domestic goats. Journal of General Virology 82: 227232.
, T. C. MCGUIRE, U. MULLER-DOBLIES, AND T. B. CRAWFORD. 2001b. A simpler, more sensitive competitive inhibition enzyme-linked immunosorbent assay for detection of antibody to malignant catarrhal fever virus. Journal of Veterinary Diagnostic Investigation 13: 361364.
, K. GAILBREATH, L. C. BENDER, K. WEST, J. KELLER, AND T. B. CRAWFORD. 2003a. Evidence of three new members of malignant catarrhal fever virus group in muskox (Ovibos moschatus), Nubian ibex (Capra nubiana), and gemsbok (Oryx gazella). Journal of Wildlife Diseases 39: 875880.[Abstract]
, A. WUNSCHMANN, J. KELLER, D. G. HALL, AND T. B. CRAWFORD. 2003b. Caprine herpesvirus-2-associated malignant catarrhal fever in white-tailed deer (Odocoileus virginianus). Journal of Veterinary Diagnostic Investigation 15: 4649.
OTOOLE, D., H. LI, D. MILLER, W. R. WILLIAMS, AND T. B. CRAWFORD. 1997. Chronic and recovered cases of sheep-associated malignant catarrhal fever in cattle. Veterinary Record 140: 519524.
PLOWRIGHT, W. 1990. Malignant catarrhal fever virus. In Virus infections of ruminants, Z. Dinter and B. Morein (eds.). Elsevier Science Publishers B.V., New York, New York, pp. 123150.
, R. D. FERRIS, AND G. R. SCOTT. 1960. Blue wildebeest and the aetiological agent of malignant catarrhal fever. Nature 188: 11671169.[Medline]
REID, H. W., D. BUXTON, W. CORRIGALL, A. R. HUNTER, D. A. MCMARTIN, AND R. RUSHTON. 1979. An outbreak of malignant catarrhal fever in red deer (Cervus elaphus). Veterinary Record 104: 120123.[Abstract]
, , I. POW, AND J. FINLAYSON. 1986. Malignant catarrhal fever: experimental transmission of the "sheep- associated" form of the disease from cattle and deer to cattle, deer, rabbits and hamsters. Research in Veterinary Science 41: 7681.[Medline]
STATISTICS NORWAY. 2005. Domestic animals, by county. In Agricultural Statistics 2003. Official Statistics of Norway, Oslo/Kongsvinger, Norway, pp. 4546 (in Norwegian).
THAM, K. M. 1997. Molecular and clinicopathological diagnosis of malignant catarrhal fever in cattle, deer and buffalo in New Zealand. Veterinary Record 141: 303306.
VAN DEVANTER, D. R., P. WARRENER, L. BENNETT, E. R. SCHULTZ, S. COULTER, R. L. GARBER, AND T. M. ROSE. 1996. Detection and analysis of diverse herpesviral species by consensus primer PCR. Journal of Clinical Microbiology 34: 16661671.[Abstract]
VIKOREN, T., J. THARALDSEN, B. FREDRIKSEN, AND K. HANDELAND. 2004. Prevalence of Toxoplasma gondii antibodies in wild red deer, roe deer, moose, and reindeer from Norway. Veterinary Parasitology 120: 159169.[Medline]
WARSAME, I. Y., AND M. STEEN. 1989. Malignant catarrhal fever in wild Swedish moose (Alces alces L). Rangifer 9: 5157.
WILLIAMS, E. S., E. T. THORNE, AND H. A. DAWSON. 1984. Malignant catarrhal fever in a Shiras moose (Alces alces shirasi Nelson). Journal of Wildlife Diseases 20: 230232.[Medline]
ZARNKE, R. L., H. LI, AND T. B. CRAWFORD. 2002. Serum antibody prevalence of malignant catarrhal fever viruses in seven wildlife species from Alaska. Journal of Wildlife Diseases 38: 500504.[Abstract]
Received for publication 2 November 2005.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |